These world-class researchers will:
- Discover and explain how immune cells interact with islets and beta cells in T1D
- Generate islets and immune cells from stem cells as the basis for next-generation cell therapies
- Develop an islet transplant protocol that will induce tolerance and not require immunosuppression
Research Team
Aaron J. Kowalski, Ph.D., JDRF
Esther Latres, Ph.D.,JDRF
Matthias Hebrok, Ph.D., UCSF
Seung Kim, M.D., Ph.D., Stanford University
Mark Anderson, M.D., Ph.D., UCSF
Jeffrey Bluestone, Ph.D., UCSF
Kyle Loh, Ph.D., Stanford University
Alexander Marson, M.D., Ph.D., UCSF
Everett Meyer, M.D., Ph.D., Stanford University
Audrey Parent, Ph.D., UCSF
Judith Shizuru, M.D., Stanford University
Julie Sneddon, Ph.D., UCSF
Qizhi Tang, Ph.D., UCSF
Linda Vo, Ph.D., UCSF
Jimmie Ye, Ph.D., UCSF
“One of the central challenges in type 1 diabetes has been identifying and targeting interactions required for autoimmune assault of human islets by immune cells. This team of superb and innovative investigators will combine novel hypotheses with modern tools to address such outstanding questions in type 1 diabetes pathogenesis. We envision that successful investigations in this crucial area of type 1 diabetes research by this Center of Excellence team will enable cell-based replacement therapies to move us closer to a cure for type 1 diabetes.”
Matthias Hebrok, Ph.D., University of California, San Francisco, and Seung Kim, M.D., Ph.D., Stanford University
News & Blogs
-
JDRF, the leading global organization funding type 1 diabetes (T1D) research, today announced the launch of the JDRF Northern California Center of Excellence, to accelerate high-impact research at Stanford University and the University of California, San Francisco, to develop cures for T1D.
-
Fall 2020 Progress Report
-
Spring 2020 Progress Report
Support our Work
Contact us to help us advance this critical work in curing T1D and improving lives.
